MK-0752

Generic Name: MK-0752

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₁H_₂₁ClF_₂O_₄S

CAS Number: 471905-41-6

Unique Ingredient Identifier: 9JD9B4S53T

Background: Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Intravenous administration of blood–brain barrier-crossing conjugates facilitate

Advances in siRNA delivery, oligonucleotide drug delivery, RNA therapeutics, overcoming cellular barriers for RNA therapeutics, and blood–brain barrier penetration strategies are highlighted through various studies and clinical trials.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy